This episode is hosted by Josie Baker, MS, LGC, and features Jeremy Davis, MD, a National Cancer Institute (NIH) surgical oncologist. Together, they discuss Dr. Davis’ recent article published in the Journal of Medical Genetics  titled “Decision-making and regret in patients with germline CDH1 variants undergoing prophylactic total gastrectomy.” This podcast was released during  Patient Experience Week.   Read our blog post to learn more about this podcast HERE ..read more

This episode is hosted by Emma Keel, MS, CGC, and features Megan Hoenig, MS, MPH, CGC a certified genetic counselor at the Mayo Clinic. Together, they discuss the contribution of MLH1 constitutional methylation to Lynch syndrome diagnosis. They also explore disease definitions and mechanisms and current genetic testing guidelines while discussing the open questions in the field.  This podcast was released on #LynchSyndromeAwarenessDay.  Read our blog post "MLH1 hypermethylation during #LynchSyndromeAwarenessDay" here https://tinyurl.com/3zkurynf ..read more

This episode is hosted by Thomas Slavin, MD, FACMG, DABMD, a Chief Scientific Officer at HALO Precision Diagnostics  and features Laura Valle, PhD, a Principal Investigator, at the Catalan Institute of Oncology, IDIBELL. They discuss the position statement on the APC I1307K allele and its association with cancer predisposition which was generated by a multidisciplinary international expert group endorsed by the International Society for Gastrointestinal Hereditary Tumours (InSiGHT). Read our blog post "Evidence based guidance for APC I1307K and Cancer Risk" here Stay tuned for more pod ..read more

This episode is hosted by Thomas Slavin, MD, FACMG, DABMD, a Chief Scientific Officer, and Emma Keel, MS, CGC, a genetic counselor, who have the privilege of speaking with Danielle Ripley-Burgess as she shares her story and experience on "Life After Total Proctocolectomy in Lynch Syndrome.” We're incredibly grateful that she took the time to share her story with us, and we hope it will give our members and the broader #HereditaryGICancer community greater insight into the patient's perspective.  ..read more

This episode is hosted by Julie Yang, MD, a gastroenterologist at the Icann School of Medicine at Mount Sinai, New York, USA and features Toni T. Seppälä, M.D., PhD, a GI surgeon and Professor of Cancer Research at Tampere University, Helsinki, Finland. They discuss the results from a retrospective analysis published this year, “Clinical characteristics of pancreatic and biliary tract cancers in Lynch syndrome: A retrospective analysis from the Finnish National Lynch Syndrome Research Registry,"  which can be found here. Read our blog post "Insights gained from the largest cohort of pat ..read more

This episode is hosted by Josie Baker, MS, CGC, a genetic counselor at The Ohio State University, and features Rachael Lopez, MPH, RD, CSO, a clinical research dietitian at the National Institutes of Health.  Together they discuss the considerations for individuals with Hereditary Diffuse Gastric Cancer Syndrome when considering a prophylactic gastrectomy. This episode highlights the professional experience when working with these individuals before and after surgery, as well as the challenges individuals may face during this process.  ..read more

This episode is hosted by Pooja Dharwadkar, M.D, assistant professor at the University of California San Francisco, and features a discussion between Carol Burke, M.D, codirector of the Hereditary Cancer Clinic at the Cleveland Clinic; Robert Hüneburg, M.D, gastroenterologist at the National Center for Hereditary Tumor Syndromes at University Hospital Bonn in Bonn, Germany; and Bryson Katona, M.D, director of the GI Cancer Genetics and Cancer Risk Evaluation programs at the Hospital of the University of Pennsylvania in Philadelphia, PA. We discuss the benefits of upper GI cancer surveillance i ..read more

On the occasion of the 2022 #PrevivorDay and #HereditaryCancerWeek, we're delighted to bring you a podcast debate as part of the CGA-IGC 2022 Podcast Series - Episode 6. This episode is hosted by Michael J. Hall, MD, MS, Fox Chase Cancer Centre and features Heather Hampel, MS, CGC, City of Hope and Matthew B. Yurgelun, MD, Dana-Farber Cancer Institute. The debate features Professor Heather Hampel and Dr Matthew Yurgelun going head to head over "Is it Time for Universal Germline Genetic Testing for All GI Cancers?", which was published in the Journal of Clinical Oncology can be found here ..read more

This episode is hosted by Beth Dudley, MS, MPH, CGC, University of Pittsburgh Medical Center and features Michael G. Goggins, M.B.B.CH., M.D., The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions. Together they discuss “The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival” which was published in the Journal of Clinical Oncology and found here: https://pubmed.ncbi.nlm.nih.gov/35704792/ This episode was recorded on June 21st, 2022 and reflects expert opinion at the time of the recording ..read more

This episode is hosted by Joshua Sommovilla, M.D, The Sanford R. Weiss, MD Center for Hereditary Colorectal Neoplasia at the Cleveland Clinic and features Matthew Kalady, M.D, The Ohio State University Wexner Medical Center and Mohammad Abbas, M.D., MPH, Northwestern University. Together they discuss “Evaluation of Urinalysis-Based Screening for Urothelial Carcinoma in Patients With Lynch Syndrome” which was published in the Journal of Dis Colon Rectum. and found here: https://pubmed.ncbi.nlm.nih.gov/34882627/ This episode was recorded on April 25th, 2022 and reflects expert opinion at the ti ..read more